Semaglutide
$110.00
Overview
Research-use GLP-1 receptor analogue supplied for studies of incretin signaling, glucose-regulation pathways, and metabolic models.
- Concentration
- 10 mg
- Stock
- In stock
Material profile
Semaglutide is a modified GLP-1 receptor analogue used in research models of incretin signaling and metabolic pathway biology. Pattern lists this material for controlled laboratory research.
- Research Targets
- GLP-1 receptor signaling, pancreatic beta-cell pathway models, central appetite-regulation circuits, gastric-motility signaling.
- Key Feature
- Modified GLP-1 analogue with albumin-binding design elements for experimental pathway studies.
- Research Focus Areas
- Incretin biology, glucose-regulation pathway models, satiety signaling, metabolic response studies.
- Common Models
- Pancreatic beta-cell assays, rodent metabolic profiling, receptor-signaling systems.
- Mechanistic Interests
- GLP-1 receptor activation, insulin and glucagon signaling markers, cAMP pathway dynamics, gastric-emptying pathway models.
- Use Boundary
- Research use only; not for human or veterinary use; no diagnostic, therapeutic, or consumption use is implied.
